Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.
Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA. Bar-Or A, et al. Among authors: hartung hp. Trends Mol Med. 2020 Mar;26(3):296-310. doi: 10.1016/j.molmed.2019.11.003. Epub 2019 Dec 17. Trends Mol Med. 2020. PMID: 31862243 Free PMC article. Review.
New immunopathologic insights into multiple sclerosis.
Hemmer B, Kieseier B, Cepok S, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. doi: 10.1007/s11910-003-0085-y. Curr Neurol Neurosci Rep. 2003. PMID: 12691630 Free PMC article. Review.
Statins as potential therapeutic agents in multiple sclerosis.
Stüve O, Prod'homme T, Youssef S, Dunn S, Neuhaus O, Weber M, Hartung HP, Steinman L, Zamvil SS. Stüve O, et al. Among authors: hartung hp. Curr Neurol Neurosci Rep. 2004 May;4(3):237-44. doi: 10.1007/s11910-004-0044-2. Curr Neurol Neurosci Rep. 2004. PMID: 15102350 Review.
Immunopathogenesis and immunotherapy of multiple sclerosis.
Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Nat Clin Pract Neurol. 2006 Apr;2(4):201-11. doi: 10.1038/ncpneuro0154. Nat Clin Pract Neurol. 2006. PMID: 16932551 Review.
Treatment and treatment trials in multiple sclerosis.
Kieseier BC, Wiendl H, Hemmer B, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Curr Opin Neurol. 2007 Jun;20(3):286-93. doi: 10.1097/WCO.0b013e3281568b80. Curr Opin Neurol. 2007. PMID: 17495622 Review.
Pharmacological treatment of early multiple sclerosis.
Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. Stüve O, et al. Among authors: hartung hp. Drugs. 2008;68(1):73-83. doi: 10.2165/00003495-200868010-00005. Drugs. 2008. PMID: 18081373 Review.
Cerebrospinal fluid biomarkers in multiple sclerosis.
Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK; BioMS Study Group. Tumani H, et al. Among authors: hartung hp. Neurobiol Dis. 2009 Aug;35(2):117-27. doi: 10.1016/j.nbd.2009.04.010. Epub 2009 May 5. Neurobiol Dis. 2009. PMID: 19426803 Review.
1,122 results